Literature DB >> 8857332

Evaluation of feline leukemia virus control measures.

S R Lubkin1, J Romatowski, M Zhu, P M Kulesa, K A White.   

Abstract

A susceptible-infected-recovered-susceptible (SIRS) model of the epidemiology of feline leukemia virus is formulated and analysed. The dynamics of the disease are dramatically different in no-risk, low-risk and high-risk subpopulations of asocial, free roaming, and multiple cat household cats. Among low risk (<1% prevalence) free roaming cats, the model predicts that an effective immunization rate of 4% year-1, or an effective removal rate of 8% year-1 are adequate to control the disease completely. Under higher risk (10% prevalence) conditions, an effective immunization rate of 23-72% year-1 or a removal rate of 69-145% year-1 are required for control. At very high (30%) prevalence rates, even heroic measures may not suffice to substantially reduce disease prevalence: a vaccination rate of 100% year-1 even if attainable, would only slightly reduce disease prevalence from 30% to 29%. We conclude that the current estimated effective feline leukemia virus immunization rate of 11-19% of the general population is inadequate to provide herd immunity in the subpopulation of cats which are genuinely at risk of infection. A substantial increase in the vaccination rate and/or intensification of test and removal efforts in the at risk population would be required to attain an effective level of protection.

Entities:  

Mesh:

Year:  1996        PMID: 8857332     DOI: 10.1006/jtbi.1996.0006

Source DB:  PubMed          Journal:  J Theor Biol        ISSN: 0022-5193            Impact factor:   2.691


  3 in total

1.  Dynamics of a feline retrovirus (FeLV) in host populations with variable spatial structure.

Authors:  E Fromont; D Pontier; M Langlais
Journal:  Proc Biol Sci       Date:  1998-06-22       Impact factor: 5.349

2.  Epizootiology and management of feline leukemia virus in the Florida puma.

Authors:  Mark W Cunningham; Meredith A Brown; David B Shindle; Scott P Terrell; Kathleen A Hayes; Bambi C Ferree; R T McBride; Emmett L Blankenship; Deborah Jansen; Scott B Citino; Melody E Roelke; Richard A Kiltie; Jennifer L Troyer; Stephen J O'Brien
Journal:  J Wildl Dis       Date:  2008-07       Impact factor: 1.535

Review 3.  DNA vaccines in veterinary use.

Authors:  Laurel Redding; David B Weiner
Journal:  Expert Rev Vaccines       Date:  2009-09       Impact factor: 5.217

  3 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.